1 Purine analogues have been examined for anxiolytic‐ and anxiogenic‐like activity in mice, by use of the elevated plus‐maze. 2 The selective A1 receptor agonist, N6‐cyclopentyladenosine (CPA) had marked anxiolytic‐like activity at 10 and 50 μ kg−1, with no effect on locomotor performance at these doses. 3 The A1 selective adenosine receptor antagonist, 1,3‐dipropyl‐8‐cyclopentylxanthine (CPX) had no significant effect on anxiety‐related measures or locomotor behaviour, but blocked the anxiolytic‐like activity of CPA. The hydrophilk xanthine, 8‐(p‐sulphophenyl) theophylline did not prevent anxiolysis by CPA. 4 Caffeine had anxiogenic‐like activity at 30 mg kg−1 which was prevented by CPA at 50 μg kg−1. 5 The A2 receptor agonist, N6‐(2‐(3,5‐dimethoxyphenyl)‐2‐(2‐methylphenyl)‐ethyl)adenosine (DPMA) had no effect on anxiety behaviour but depressed locomotor activity at the highest dose tested of 1 mg kg−1. The A2 receptor antagonist, 1,3‐dimethyl‐l‐propargylxanthine (DMPX) had no effect on anxiety‐related measures or locomotion and did not modify the anxiolytic‐like activity of CPA. 6 Administration of DPMA in combination with anxiolytic doses of CPA prevented the anxiolytic‐like activity of the latter. 7 The results suggest that the selective activation of central A1 adenosine receptors induces anxiolytic‐like behaviour, while the activation of A2 sites causes locomotor depression and reduces the effects of A1 receptor activation. The absence of any effect of CPX alone suggests that the receptors involved in modulating behaviour in the elevated plus‐maze in mice are not activated tonically by endogenous adenosine.
British Journal of Pharmacology – Wiley
Published: Oct 1, 1995
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera